Abstract
AbstractM proteins of the widespread and potentially deadly bacterial pathogen Streptococcus pyogenes (Strep A) are immunodominant targets of opsonizing antibodies. However, the antigenic sequence variability of the M protein into >220 M types has limited its utility as a vaccine immunogen, as antibody recognition is usually type-specific. At present no vaccine against Strep A exists. Unlike type-specific antibodies, C4BP binds type-promiscuously to M proteins. We recently showed that this was due to a three-dimensional (3D) pattern of amino acids that is conserved in numerous M types. We hypothesized that M protein immunogens biased towards the 3D pattern and away from variable sequences would evoke a broadly protective response. We show here that an immunogen containing only 34 amino acids of M2 protein retained C4BP- binding and was sufficient to evoke antibodies that were cross-reactive and opsonophagocytic against multiple M types. These proof-of-principle experiments provide significant evidence that an essential Strep A virulence trait (i.e., C4BP binding) can be targeted in the design of an immunogen that evokes a broadly protective response.
Publisher
Cold Spring Harbor Laboratory
Reference38 articles.
1. Rodriguez-Iturbe B , Haas M. Post-Streptococcal Glomerulonephritis. In: Ferretti JJ , Stevens DL , Fischetti VA , editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations. 2016/02/12 ed: University of Oklahoma Health Sciences Center; 2016.
2. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015
3. The global burden of group A streptococcal diseases